The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better than average stocks (as part of a diversified portfolio). For example, the ...

RENO, NV--(Marketwired - Oct 4, 2016) - Enhance Skin Products Inc., (OTC PINK: EHSK) is pleased to make the following announcement: Enhance Skin Products Inc., a pioneer in hyaluronan ("HA") research ...

(Alliance News) - Integumen PLC on Friday announced it had agreed terms for the acquisition of Modern Water PLC in an all-share deal that values the London-based wastewater firm at around GBP21.3 ...

Dublin-headquartered health technology company Integumen has agreed to acquire an Essex business which has developed a system to make biodegradable plastic components that can be used in the packaging ...

LONDON, Sept 24 (Reuters) - Integumen (SKINI.L), opens new tab, a British company that developed a system to detect the COVID-19 virus in waste water, said the same technology could be deployed in a ...

(Sharecast News) - Life sciences outfit Integumen agreed to acquire data management firm RinoCloud for a total of £3m on Friday as part of its efforts to build out its Labskin AI platform.Integumen, ...

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, has entered into a collaboration with Integumen plc (Integumen) to evaluate recently generated Affimer reagents that bind the ...

Drug development firm Venn Life Sciences said it reported an overall loss of €1.5 million for last year as charges related to its investment in Dalkey-based Integumen hit its balance sheet. The ...

Shares in Irish personal healthcare company Integumen have been suspended from trading following the company announcing its intention to acquire London-based plastics business Cellulac in a reverse ...

Integumen , a British company that developed a system to detect the COVID-19 virus in waste water, said the same technology could be deployed in a personalised breath test that could become an ...

Dalkey-based healthcare company Integumen is planning to raise £2.25m (€2.6m) via a listing on the Alternative Investment Market in London. The company, chaired by Venn Life Sciences' chief executive ...